Literature DB >> 4818459

Isolation and characterization of the proenzyme form of the C1r subunit of the first complement component.

G Valet, N R Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4818459

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

1.  Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.

Authors:  Ming Li; Rahasson R Ager; Deborah A Fraser; Natalia O Tjokro; Andrea J Tenner
Journal:  Mol Immunol       Date:  2008-04-08       Impact factor: 4.407

2.  Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.

Authors:  S J Perkins
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

3.  Structural features of the first component of human complement, C1, as revealed by surface iodination.

Authors:  C L Villiers; S Chesne; M B Lacroix; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

4.  Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.

Authors:  B Ghebrehiwet; B P Randazzo; J T Dunn; M Silverberg; A P Kaplan
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Primary structure of the A chain of human complement-classical-pathway enzyme C1r. N-terminal sequences and alignment of autolytic fragments and CNBr-cleavage peptides.

Authors:  J Gagnon; G J Arlaud
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

6.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

7.  Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.

Authors:  S Chesne; C L Villiers; G J Arlaud; M B Lacroix; M G Colomb
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

8.  The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.

Authors:  G J Arlaud; J Gagnon; R R Porter
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

9.  In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.

Authors:  R Veerhuis; L A van Es; M R Daha
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

10.  Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.

Authors:  J C Bensa; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.